- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Versigent Ltd (VGNT)
NYSE
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.81
47.01
52 wk Range
26.34
50.89
Versigent (VGNT) Earnings Dates & Reports
Find detailed information about the financial performance of Versigent Ltd, including the latest Versigent earnings report and upcoming earnings date. Review key figures such as the VGNT share price, VGNT EPS (earnings per share), and revenue compared against their previously forecasted numbers.
To view advanced VGNT earnings and revenue information, sign up for your very own InvestingPro account.
To view advanced VGNT earnings and revenue information, sign up for your very own InvestingPro account.
Latest Release
04/08/2026
EPS / Forecast
1.92 / 1.50
Revenue / Forecast
2.44B / 2.3B
All numbers in USD
Versigent Ltd Earnings Call Summary for Q2/2026
- Versigent Q2 EPS of $1.92 beat estimates by 28%; revenue of $2.44B topped forecasts by 6.1%; shares surged 7.89% to $45.36 in premarket trading.
- Adjusted EBITDA rose 25% YoY to $272M with margin expanding to 11.1%; company launched record 39 global programs while maintaining 99%+ quality delivery.
- Full-year revenue guidance raised to $9.4B-$9.6B from $9.1B-$9.4B, driven by copper pass-throughs and stronger Chinese renminbi, not underlying profit changes.
- Company declared first quarterly dividend and maintained $250M buyback authorization; net leverage at 1.8x with total liquidity of $1.4B including undrawn revolver.
- Management reaffirmed 2027 growth framework of 3-4% based on production growth and market share gains; warned of near-term pressure from lower industry production.
Last Updated: 04/08/2026, 15:42
Read Full TranscriptFAQ
What Is Versigent's Earnings Per Share (TTM)?
The Versigent EPS for trailing twelve months (TTM) is 7.21.
When Is The Next Versigent (VGNT) Earnings Date?
Versigent will release its next earnings report on 02/12/2026, according to their financial calendar.
What Is Versigent’s Revenue Forecasts For Upcoming Quarters?
Versigent’s revenue forecast is 2.39B.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.